Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of the Efficacy of Concomitant Therapy for Eradication of Helicobacter Pylori
Brief Summary: If we compare eradication rate of Helicobacter pylori divided to 4 groups: amoxicillin, rabeprazole, clarithromycin(AOC), amoxicillin, rabeprazole, metronidazole(AOM), treated with amoxicillin, rabeprazole for 5 day, followed by clarithromycin, metronidazole, rabeprazole for 5 days(sequential), amoxicillin, clarithromycin, metronidazole, rabeprazole(concomitant), then the eradication rate of concomitant group will be the highest.


Options:
A: Arm Label: triple therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: 10 day triple therapy | Arm Label: Concomitant therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: 10 day sequential therapy | Arm Label: sequential therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: 10 day concomitant therapy | Intervention Type: DRUG; Name: 10 day triple therapy; Assigned to Arm(s): triple therapy | Intervention Type: DRUG; Name: 10 day sequential therapy; Assigned to Arm(s): Concomitant therapy | Intervention Type: DRUG; Name: 10 day concomitant therapy; Assigned to Arm(s): sequential therapy
B: Arm Label: 7-day quadruple therapy; Type: EXPERIMENTAL; Interventions: Drug: 7-day quadruple therapy | Arm Label: 10-day sequential therapy; Type: EXPERIMENTAL; Interventions: Drug: 10-day sequential therapy | Arm Label: 7-day standard triple therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: 7-day standard triple therapy | Intervention Type: DRUG; Name: 7-day quadruple therapy; Assigned to Arm(s): 7-day quadruple therapy | Intervention Type: DRUG; Name: 10-day sequential therapy; Assigned to Arm(s): 10-day sequential therapy | Intervention Type: DRUG; Name: 7-day standard triple therapy; Assigned to Arm(s): 7-day standard triple therapy
C: Arm Label: AOC group; Type: EXPERIMENTAL; Interventions: Drug: amoxicillin, clarithromycin, metronidazole, rabeprazole | Arm Label: AOM group; Type: EXPERIMENTAL; Interventions: Drug: amoxicillin, clarithromycin, metronidazole, rabeprazole | Arm Label: Sequential group; Type: EXPERIMENTAL; Interventions: Drug: amoxicillin, clarithromycin, metronidazole, rabeprazole | Arm Label: concomitant group; Type: EXPERIMENTAL; Interventions: Drug: amoxicillin, clarithromycin, metronidazole, rabeprazole | Intervention Type: DRUG; Name: amoxicillin, clarithromycin, metronidazole, rabeprazole; Assigned to Arm(s): AOC group, AOM group, Sequential group, concomitant group
D: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Drug: Sequential therapy for 14 days | Arm Label: Group B: Sequential therapy for 10 days; Type: EXPERIMENTAL; Interventions: Drug: Sequential therapy for 10 days | Arm Label: Group C: Triple therapy for 14 days; Type: ACTIVE_COMPARATOR; Interventions: Drug: Triple therapy for 14 days | Intervention Type: DRUG; Name: Sequential therapy for 14 days; Assigned to Arm(s): Group A | Intervention Type: DRUG; Name: Sequential therapy for 10 days; Assigned to Arm(s): Group B: Sequential therapy for 10 days | Intervention Type: DRUG; Name: Triple therapy for 14 days; Assigned to Arm(s): Group C: Triple therapy for 14 days

Answer: C